PSC
DBVT

Patient Square Capital’s DBV Technologies DBVT Stock Holding History

Patient Square Capital’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5M Buy
693,534
+334,484
+93% +$6.99M 2.57% 10
2025
Q4 		$6.88M Buy
+359,050
New +$5.61M 1.47% 14

Other funds holding DBVT

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Patient Square Capital's DBVT Position: Q1 2026 in Review

Patient Square Capital increased its DBV Technologies (DBVT) stake by 93% in Q1 2026, buying an estimated $6.99M and bringing the position to 693,534 shares worth $14.5M. The position accounts for 2.57% of the portfolio, ranked #10.

Patient Square Capital first reported a position in DBVT in Q4 2025 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold DBVT as of Q1 2026.

  • Patient Square Capital held 693,534 shares of DBV Technologies worth $14.5M as of Q1 2026.
  • Patient Square Capital bought 334,484 DBV Technologies shares in Q1 2026, an estimated $6.99M.
  • DBV Technologies made up 2.57% of Patient Square Capital's portfolio in Q1 2026, its #10 holding.
  • Patient Square Capital first reported a position in DBV Technologies in Q4 2025 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held DBV Technologies as of Q1 2026.

Based on Patient Square Capital's 13F filing for Q1 2026, filed 15 May 2026.